Literature DB >> 27720712

Relapsing Acute Axonal Neuropathy in Hereditary Fructose Intolerance.

Anna Maitre1, Anna Maw1, Uma Ramaswami1, Sarah L Morley2.   

Abstract

BACKGROUND: A severe neurological abnormality has not been previously described in individuals with hereditary fructose intolerance, which typically presents early in childhood with severe metabolic acidosis and hypoglycemia. PATIENT DESCRIPTION: We describe a boy who by age five years had required multiple admissions to the pediatric intensive care unit for an aggressive and atypical, relapsing and remitting neuropathy with features of acute motor axonal neuropathy (AMAN). It was later discovered that he also had undiagnosed hereditary fructose intolerance, and the severity and frequency of his neurological episodes diminished following an exclusion diet. His asymptomatic younger brother was diagnosed with hereditary fructose intolerance on screening. He is on a fructose-free diet and has not developed neurological symptoms.
CONCLUSIONS: Ongoing low-level exposure to fructose prior to diagnosis may have contributed to our patient's neurological dysfunction. Early diagnosis and treatment may prevent neurological complications of hereditary fructose intolerance.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  hereditary fructose intolerance; motor neuropathy; relapsing neuropathy

Mesh:

Year:  2016        PMID: 27720712     DOI: 10.1016/j.pediatrneurol.2016.06.021

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

Review 1.  Hereditary fructose intolerance: A comprehensive review.

Authors:  Sumit Kumar Singh; Moinak Sen Sarma
Journal:  World J Clin Pediatr       Date:  2022-07-09

2.  Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).

Authors:  Jennifer M Mongiovi; Gary R Zirpoli; Rikki Cannioto; Lara E Sucheston-Campbell; Dawn L Hershman; Joseph M Unger; Halle C F Moore; James A Stewart; Claudine Isaacs; Timothy J Hobday; Muhammad Salim; Gabriel N Hortobagyi; Julie R Gralow; G Thomas Budd; Kathy S Albain; Christine B Ambrosone; Susan E McCann
Journal:  Breast Cancer Res       Date:  2018-11-28       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.